physiciansweekly.com
Monitoring Crohn's Disease After Surgery with Fecal Calprotectin - Physician's Weekly
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help detect recurrence and guide decisions about further testing or treatment.
Adults with Crohn's disease who have an ileostomy, clinicians who manage postoperative IBD patients, and researchers studying biomarkers for IBD monitoring.
What To Know
This article summarizes a BMC Gastroenterology study testing whether fecal calprotectin (FC) measured from ileostomy output can detect postoperative small-bowel inflammation in people with Crohn's disease.
The study found higher FC levels in patients with active inflammation versus remission and reported similar performance for a point-of-care FC test and ELISA. The researchers analyzed retrospective data from patients with an ileostomy who had FC measured at the same time as imaging or endoscopy.
FC concentrations from ileostomy output were higher when objective evidence showed active small-bowel inflammation. The study compared a point-of-care FC test (FC-POCT) and an ELISA (FC-ELISA) and found no clear difference in diagnostic performance between them.
How this might affect care: If validated in prospective studies, measuring FC from ileostomy output could offer a noninvasive way to monitor postoperative small-bowel inflammation and help guide when to pursue imaging, endoscopy, or treatment adjustments.
This research does not itself change care but points to a potential monitoring option for patients with ileostomies. Practical note: The article calls for further prospective work and standardized FC thresholds before routine clinical use.
This report summarizes a retrospective single-study analysis; it is not a randomized trial. Authors note the need for prospective validation and standardized thresholds before FC from ileostomy output can be recommended for routine clinical practice.
